Endoscopy 2012; 44(08): 754-758
DOI: 10.1055/s-0032-1309819
Original article
© Georg Thieme Verlag KG Stuttgart · New York

The use of Pillcam Colon in assessing mucosal inflammation in ulcerative colitis: a multicenter study

J. Sung
1   Institute of Digestive Disease, The Chinese University of Hong Kong, Hong Kong
,
K. Y. Ho
2   National University Hospital, National University of Singapore, Singapore
,
H. M. Chiu
3   Department of Medicine, National Taiwan University, Taipei, Taiwan
,
J. Ching
1   Institute of Digestive Disease, The Chinese University of Hong Kong, Hong Kong
,
S. Travis
4   Translational Gastroenterology Unit, Nuffield Department of Medicine, University of Oxford, Oxford, United Kingdom
,
R. Peled
5   GIVEN Imaging, Yoqneam, Israel
› Author Affiliations
Further Information

Publication History

received 23 November 2011

accepted after revision 12 April 2012

Publication Date:
13 June 2012 (online)

Background and study aim: Treatment of ulcerative colitis should be tailored to the severity of colonic inflammation, which in the past has been gauged mainly by clinical features and biochemical parameters. Recently, mucosal healing has been proposed as a standard to guide therapy. The aim of this multicenter study was to test whether mucosal appearance, as reported by colon capsule endoscopy (CCE), can be used to differentiate active from inactive ulcerative colitis.

Patients and methods: Adult patients from Hong Kong, Singapore, and Taiwan who were suspected or known to have ulcerative colitis were included in this prospective study. CCE and conventional optical colonoscopy were offered to these patients on the same day after receiving standard bowel preparation. The primary endpoint was the accuracy of CCE in assessing colonic inflammation (defined as the presence of ulcers, erythema, erosions, edema, exudates in mucosa), using optical colonoscopy as the gold standard.

Results: At total of 100 patients (42 females; median age 50 years; range 22 – 68 years) were enrolled. Four cases were excluded from the analysis due to technical failure or slow transit of the capsule. In nine patients, the capsule was not excreted within 8.5 hours and required retrieval during colonoscopy. The sensitivity of CCE to detect active colonic inflammation was 89 % (95 % confidence interval [CI] 80 – 95) and specificity was 75 % (95 %CI 51 – 90). The positive and negative predictive values of CCE for colonic inflammation were 93 % (95 %CI 84 – 97) and 65 % (95 %CI 43 – 83), respectively. No serious adverse event related to the CCE procedure or preparation was reported.

Conclusion: CCE is a safe procedure to monitor mucosal healing in ulcerative colitis. However, at this stage, CCE cannot be recommended to replace conventional colonoscopy in the management of this condition.

 
  • References

  • 1 Kornbluth A, Sachar DB. Practice Parameter Committee of the American College of Gastroenterology. Ulcerative colitis practice guidelines in adults: American College of Gastroenterology; Practice Parameter Committee. Am J Gastroenterol 2010; 105: 501-523
  • 2 Travis SPL, Stange EF, Lémann M et al. for the European Crohn’s and Colitis Organization (ECCO) European Consensus on the diagnosis and management of ulcerative colitis: current management. J Crohns Colitis 2008; 2: 24-62
  • 3 Ooi CJ, Fock KM, Makharia GK et al. The Asia Pacific Consensus on Ulcerative colitis. J Gastroenterol Hepatol 2010; 25: 453-468
  • 4 Kane S. Endoscopic healing should be a goal for everyone with ulcerative colitis. Inflamm Bowel Dis 2008; DOI: 10.1002/ibd.20779.
  • 5 Lichtenstein GR, Rutgeerts P. Importance of mucosal healing in ulcerative colitis. Inflamm Bowel Dis 2010; 16: 338-346
  • 6 de Chambrun GP, Peyrin-Biroulet L, Lemann M et al. Clinical implications of mucosal healing for the management of IBD. Nat Rev Gastroenterol Hepatol 2010; 7: 15-29
  • 7 Boureille A, Ignjatovic A, Aabaken L et al. on behalf of the Organisation Mondial d’Endoscopie Digestif (OMED) and the European Crohn’s and Colitis Organization (ECCO) Role of small bowel endoscopy in the management of patients with IBD: an international OMED-ECCO Consensus. . Endoscopy 2009; 41: 618-637
  • 8 Triester SL, Leighton JA, Leontiadis GI et al. A meta-analysis of capsule endoscopy compared to other modalities in patients with non-stricturing small bowel Crohn’s disease. Am J Gastroenterol 2006; 101: 954-964
  • 9 Eliakim R, Fireman Z, Gralnek IM et al. Evaluation of the PillCam Colon capsule in the detection of colonic pathology: results of the first multicenter, prospective, comparative study. Endoscopy 2006; 38: 963-970
  • 10 Schoofs N, Deviere J, Van Gossum A et al. PillCam colon capsule endoscopy compared with colonoscopy for colorectal tumor diagnosis: a prospective pilot study. Endoscopy 2006; 38: 971-977
  • 11 Van Gossum A, Navas MM, Fernandez-Urien I et al. Capsule endoscopy versus colonoscopy for the detection of polyps and cancer. N Engl J Med 2009; 361: 264-270
  • 12 Herrerias-Gutierrez JM, Arguelles-Arias F, Caunedo-Alvarez A et al. PillCam colon capsule for the study of colonic pathology in clinical practice. Study of agreement with colonoscopy. Rev Esp Enferm Dig 2011; 103: 69-75
  • 13 Sandborn WJ. Current directions in IBD therapy: what goals are feasible with biological modifiers?. Gastroenterology 2008; 135: 1442-1447
  • 14 Eliakim R, Yassin K, Niv Y et al. Prospective multicenter performance evaluation of the second-generation colon capsule compared with colonoscopy. Endoscopy 2009; 41: 1026-1031
  • 15 Spada C, Hassan C, Munoz-Navas M et al. Second-generation colon capsule compared with colonoscopy. Gastrointest Endosc 2011; 74: 581-589 e1. Erratum in Gastrointest Endosc 2011; 74: 1174